GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » C-Rad AB (LTS:0R44) » Definitions » Beta

C-Rad AB (LTS:0R44) Beta : 0.02 (As of May. 30, 2024)


View and export this data going back to 2014. Start your Free Trial

What is C-Rad AB Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-05-30), C-Rad AB's Beta is 0.02.


C-Rad AB Beta Historical Data

The historical data trend for C-Rad AB's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C-Rad AB Beta Chart

C-Rad AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.74 - - -0.05

C-Rad AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -0.01 -0.05 -

Competitive Comparison of C-Rad AB's Beta

For the Medical Devices subindustry, C-Rad AB's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C-Rad AB's Beta Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, C-Rad AB's Beta distribution charts can be found below:

* The bar in red indicates where C-Rad AB's Beta falls into.



C-Rad AB Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


C-Rad AB  (LTS:0R44) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


C-Rad AB Beta Related Terms

Thank you for viewing the detailed overview of C-Rad AB's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


C-Rad AB (LTS:0R44) Business Description

Traded in Other Exchanges
Address
Sjukhusvägen 12K, Uppsala, SWE, 753 09
C-Rad AB is a Sweden based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. The operating segments of the group are the Positioning segment which includes development and sales of products in the field of patient positioning during radiotherapy, including catalyst, sentinel, and HIT lasers; and the Imaging segment which includes the development of imaging devices and detectors for cancer treatments and dosimetry. It generates maximum revenue from the Positioning segment. The firm sells its products in Sweden and internationally.

C-Rad AB (LTS:0R44) Headlines

No Headlines